pots and tirzepatide Microdose Anyone here have POTS? :

In Phase 1 and Phase 2 human studies (20222023) subjects showed weight reductions of up to 24 % of baseline over 48 weeks

Millions have now discovered that Ozempic and Wegovy were spectacularly effective sledgehammers, blunt, decisive, indiscriminate

Rodent models are the most frequently used GC-induced skin atrophy models

Thats a user population that includes not only weight lifters and bodybuilders but also people at risk for: Sarcopenia The worldwide prevalence of sarcopenia, or age-related muscle loss, is 10-16%, so its far from uncommon.31 And because people begin to lose 3-8% of their existing muscle mass with every proceeding decade of adult life, it behooves you to take active measures to preserve the lean mass you have.32 Otherwise, you may find yourself struggling with physical weakness and decreased physiological function as you grow older.33 Resistance training can mitigate the risk, and a growth hormone secretagogue peptide can support your resistance training